Gateway 2011: Sensient Pharmaceutical Coating Systems - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2011: Sensient Pharmaceutical Coating Systems

Sensient® Pharmaceutical Coating Systems is a global leader in superior coating systems, brand-defining color solutions, and enhanced product performance for the pharmaceutical and nutraceutical markets. A single source for complete coating and visual enhancement solutions, we’re committed to innovation not only in our superior products and solutions but also in our personalized, responsive service.

Sensient Pharmaceutical Coating Systems leads the industry in the development and manufacture of innovative coatings and colors for the pharmaceutical and nutraceutical industries. Our coatings, excipients, and imprint inks offer visual and functional attributes necessary for brand definition, product identification, and trademark protection. Please visit us at AAPS 2011 at Booth #1419.

Sensient Pharmaceutical Coating Systems
2515 N. Jefferson, St. Louis, MO 63106
Phone: 800.325.8110


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here